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Abstract 
Urethane-induced cortical slow wave activity (SWA) spreads into the basal ganglia in dopamine 
(DA)-depleted 6-OHDA rat models of Parkinson's disease (PD). The cortical SWA during 
physiological sleep reflects the sleep need being powerfully expressed at the beginning and 
progressively reduced during sleep-time. It has been postulated that the SWA during sleep is able to 
modulate cortical plasticity.  
In order to determinate the impact of the SWA on synaptic strength and its interplay with DA, we 
simultaneously recorded the electrocorticogram (ECoG) and the corticocortical- and corticostriatal-
evoked potentials (CC-EPs, CS-EPs) during eight hours of robust urethane-induced SWA in both 
normal and PD animals. A subgroup of PD rats was assessed with repetitive apomorphine (APO) 
administrations.  
Normal animals showed a progressive reduction of SWA power during urethane-induced SWA. 
Compared to normal animals, PD animals showed lower SWA power at the start of anesthesia without 
a significant reduction over time. Accordingly, synaptic strength measured by CC- and CS-EP 
amplitudes decreased in normal but not in Parkinsonian rats. The PD animals treated with APO 
showed a CS-EP amplitude reduction comparable to normal animals. Interestingly, SWA power 
directly correlated with CS-EP amplitude in normal animals. 
These data support the hypothesis that cortical SWA is directly associated with the regulation of 
synaptic efficacy in which DA exerts a crucial role.  
Keywords: Sleep benefit, Parkinson’s disease, dopamine, slow wave activity, synaptic homeostasis 
hypothesis. 
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Statement of significance  
The present manuscript demonstrates that the SWA is able to downscale synapses when artificially 
induced with urethane. Furthermore, DA exerts a permissive role on SWA function and since it is 
clearly reduced in PD animals at the onset of sleep, on cortical plasticity too.  
The translational implication of the present results is that the alternating administration of DA-ergic 
treatment during the daytime and the complete washout during nighttime could be responsible for the 
instauration of aberrant plasticity as observed in advanced stages of PD patients. Clinical counterparts 
of the present data arise from the observation that continuous antiparkinsonian treatments, such as 
deep brain stimulation are able to improve the levodopa-induced dyskinesia that are linked to aberrant 
plasticity.  
The clinical message could be relevant on the management of PD therapy, suggesting that DA-ergic 
treatment could be initiated at PD onset with a preference for long lasting molecules able to act also 
during nighttime when SWA plays a crucial role in homeostatic processes.  
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Introduction 
SWA consists of a slow electroencephalogram (EEG) oscillation ranging between 0.1 and 4 Hz, in 
which the depolarized up-state is sustained by the activity of cortical neurons, whilst the 
hyperpolarized down-state is characterized by widespread cortical neuronal silence.1 The number of 
neurons synchronously engaged in the depolarized and hyperpolarized state determines the amplitude 
of the SWA.1 Urethane anesthesia is able to induce cortical SWA which is indistinguishable from the 
physiological SWA of non-rapid eye movement (NREM) 2,3 and therefore this anesthetic has been 
used as a model to investigate central mechanisms underlying sleep.4–6 Particularly, during SWA, 
cortical neurons show the same electrophysiological characteristics in both urethane anesthesia and 
NREM sleep.2,7 Thus, it has been postulated that urethane most likely promotes unconsciousness by 
activating the brain mechanisms involved in natural sleep.7 In animal models of Parkinson’s disease 
(PD), urethane-induced cortical SWA powerfully spreads within the basal ganglia 8–10 and this 
evidence has been linked to an excessive synchronization between cortex and basal ganglia in the 
dopamine (DA) depleted state11 interfering with motor program selection.  
Indeed, DA depletion also alters the corticostriatal synaptic plasticity, as has emerged in in vitro 
studies 12 but also in in vivo experiments.13 Of note, the corticostriatal-evoked potentials (CS-EPs) 
change their response in relation to both sleep and DA denervation. 14–18 
In physiological conditions, the amplitude of the SWA during NREM not only reflects the sleep 
needed 19 but could also contribute to the modulation of synaptic plasticity.19 Accordingly, recent 
evidence has demonstrated that sleep shrinks synapses of sensory-motor cortex in terms of synaptic 
interface and volume.20  
Indeed, the cortical sleep-like oscillations induced through electrical stimulation of the medial 
lemniscus modulates glutamatergic synaptic plasticity.21 Accordingly, the corticocortical-evoked 
potentials (CC-EPs), representative of the global cortical synaptic strength,22 increase with time spent 
awake and decrease with time spent asleep.23 
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Therefore, SWA might play a dual role in a feedback control loop in which synapses with stronger 
efficiency produce a larger SWA amplitude that subsequently operates an homeostatic 24 reduction 
of synaptic strength.25 The long-lasting depression of excitatory postsynaptic potentials could be 
triggered by the oscillatory nature of the SWA.24,26  
Given these premises, we investigate the effect and time-course of long-lasting urethane-induced 
SWA on synaptic transmission measured by an input-output (I-O) curve of the CC-EP and CS-EP. 
Subsequently, we explore the impact of chronic DA depletion and DAergic treatment on these evoked 
responses and on SWA changes.  
We hypothesize that dopaminergic denervation strongly affects SWA and the related evoked 
potentials. We used the evoked field potentials because they are a reliable tool for studying synaptic 
communication and especially excitatory post-synaptic potentials in vivo.27 Moreover, the 
monosynaptic connection of the CC-EP and CS-EP lead to a straightforward identification of the 
evoked response 23,27,28 that is linked to synaptic strength.22,23,27 We focused our study on frontal 
motor cortex evoked responses because the most substantial increase after prolonged wakefulness, as 
measured by SWA power, has been described within this region. 20,29  
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Methods 
Animals 
Experimental procedures were carried out on 16 adult male Sprague-Dawley rats (Harlan, Udine, 
Italy) that weighed between 170-200 g, corresponding to six weeks of age. The study was conducted 
at the Laboratory for Biomedical Neurosciences (LBN) in compliance with Swiss laws on animal 
experimentation and the National Institute of Health`s Guide for the Care and Use of Laboratory 
Animals. The study was approved by Ticino veterinary authorities. All procedures were performed 
with the intention of minimizing animal discomfort and stress. The rats were kept on a regular light-
dark cycle (lights on at 08:00am, lights off at 08.00pm; room temperature 20-22°C;) and were given 
food (Harlan RM Diet, Udine, Italy) and water ad libitum. The study design and the experimental 
procedures are depicted in Figure 1A,B.  
 
Unilateral Parkinsonian 6-OHDA-lesioned model 
A unilateral (right hemisphere) DA denervation was performed on 10 rats according to a standard 
protocol 28,30,31. The rats were anaesthetized with 1.5-2.5% isoflurane in oxygen and were mounted 
on a stereotaxic instrument (Stoelting Co., Wheat Lane, Wood Dale, IL, USA). Body temperature 
was maintained at 37°-38° C with a heating pad (Stoelting Co., Wheat Lane, Wood Dale, IL, USA) 
that was placed beneath the animal. After a subcutaneous injection of the local anesthetic lidocaine, 
a midline scalp incision was made and a hole (Ø ~1.0 mm) was drilled in the skull on the right side. 
The neurotoxin (30 mM saline solution of 6-OHDA containing 0.03% of ascorbic acid) was injected 
into the medial forebrain bundle (MFB; coordinates: 4.0 mm posterior of the bregma, 1.3 mm laterally 
of the midline and 7.0 mm beneath the cortical surface). Injections of 3 μl of 6-OHDA were 
administered through a 30-gauge cannula connected to a 10 μl Hamilton syringe over a period of 3 
minutes. The injection of the neurotoxin was preceded by a bolus of desipramine (25 mg/kg, i.p.) in 
order to minimize the uptake of 6-OHDA by noradrenergic neurons.  
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Tyrosine hydroxylase immunohistochemistry  
After completing the recordings, the 10 rats were sacrificed with an i.p. overdose of urethane. The 
brains were removed immediately, and then frozen at -20°C. We measured the degree of 
dopaminergic damage within the substantia nigra compacta (SNc), the ventral tegmental area (VTA) 
and the ipsilateral striatum by tyrosine hydroxylase (TH) immunostaining (Figure 1C), as reported 
elsewhere.18,28,30,32 Briefly, coronal brain 40-μm-thick sections were cut with an Oxford vibratome 
across the entire rostrocaudal extent of the striatum and midbrain. Free-floating sections were washed 
three times with Tris-buffered saline, pH 7.4, and endogenous peroxidase activity was inactivated by 
Tris-buffered saline containing 2% H2O2. The sections were rinsed with Tris-buffered saline (0.1% 
Triton X-100 and 2% normal goat serum) and incubated with 2% normal goat serum followed by 
overnight incubation at 4°C with mouse anti-TH primary antibodies (1:2000; anti-TH Chemicon, 
Millipore). Primary antibodies were detected using a secondary antibody (goat anti mouse IR800, 
Rockland, Gilbertsville). Sections were then rinsed with Tris-buffered saline, mounted on gelatin-
coated slides, dehydrated, and cover-slipped with Permount, observed and photographed with a light 
microscope. All histological samples showed absence of TH reaction with a preserved VTA 
ipsilateral to 6-OHDA injection.  
 
Electrophysiological recordings 
The electrophysiological recordings were performed under urethane anesthesia maintaining the body 
temperature at 37°-38° C with a heating pad (Stoelting Co., Wheat Lane, Wood Dale, IL, USA) that 
was placed beneath the animal. We continuously recorded the cortical surface EEG (ECoG) and 
performed the input-output (I-O) curves of the CC-EP and the CS-EP starting at the same hour in the 
morning, and then every 2 hours during eight consecutive hours in normal (n = 6) and untreated 
Parkinsonian rats (n = 5; Figure 1A,B). An additional group of Parkinsonian animals (n = 5) was 
injected with apomorphine (APO, 0.05 mg/kg, s.c.) 10 minutes before each I-O curve. Two 1mm 
diameter golden screw electrodes (gold plated screws, conical cross S1, Svenska Dentorama AB) 
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were implanted in the frontal right and left cortices (coordinates: 2 mm anterior of the bregma, 3 mm 
laterally to the midline) under urethane anesthesia.31 Furthermore, a tungsten recording electrode with 
an impedance of ~0.1 MΩ (TM33B01, World Precision Instruments, FL, USA) was implanted into 
the striatum (coordinates: 0.48 mm anterior of the bregma, 3.5 mm lateral to the midline and 4 mm 
ventral to the cortical surface).18 One reference epidural screw electrode was placed over the right 
cerebellar hemisphere.  
 
Data acquisition and stimulation protocol  
The signal was amplified (gain: 1K, band-pass filter: 1 Hz – 3 kHz; Iso-DAM8, World Precision 
Instruments, FL, USA), digitized (sampling rate: 10 kHz; Cambridge Electronic Devices, Cambridge, 
UK), and stored in a computer for offline analysis. The stimulation protocol consisted of constant 
current pulses with the following parameters: 0.3 ms duration at 0.1 Hz, 1–10 mA (AM-systems, 
Isolated Pulse Stimulator, Model 2100). The I-O characteristics of synaptically evoked intercallosal 
and cortico-striatal field potential responses were determined by increasing stimulation intensity 
stepwise from threshold to saturating response (from 1 to 10 mA). For each stimulation intensity, 
amplitudes of ten evoked responses were averaged. We sampled the CC-EP and the CS-EP every two 
hours for a total of 8 hours of recordings: 10.00am, 12.00pm, 2.00pm, 4.00pm (Fig. 1A). 
The response of the CC- and the CS-EP consisted of a complex stereotyped sequence of field 
potentials, which typically consisted of a positive-negative-positive (P1-N2-P2, Fig. 2D) waveform. 
P1 amplitude augmented with increased stimulating current.27,33 An earlier negative component (N1) 
as described elsewhere33, was likely masked by the stimulation artifact. The amplitude of the evoked 
local field potentials was determined as the voltage difference between the N2 peak and the 
subsequent P2 peak.  
Changes in the current required for an evoked response, i.e. the excitability, were determined by 
plotting the amplitude and the slope values of the CC-EP or the CS-EP during each current step vs. 
the intensity of the current injected). 
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Data and statistical analysis 
In order to demonstrate the long-lasting stability of the urethane-induced SWA, we measured the 
content of dominant power during the all ECoG recordings using a fast Fourier transform (FFT) 
algorithm (SUDSA22 script, Spike2 software; CED). The same software calculated the total power 
of delta (0.1-4 Hz), theta (5-7 Hz), beta (8-13 Hz) and gamma (15-35 Hz) for 10 minutes before each 
stimulation protocol (10.00am, 12.00pm, 02.00pm, 04.00pm). To detect changes in the total power 
at the different hours, we used a non-parametric repeated-measures two-way ANOVA followed by a 
Dunnett’s multiple comparisons test.  
Data relating the EP amplitude to different stimulus strengths were first analyzed across all groups 
with an ANOVA for repeated measures which demonstrated, as expected, an overall highly 
significant effect of stimulus strength on the amplitude but no significant difference between the three 
groups in the I-O curves (data not shown, SPSS for Windows v9, SPSS; Chicago, IL). Therefore, we 
expressed all amplitude and slope values as percentages of the plateau at baseline (set to 100%) and 
analyzed the time course of the I-O curves by nonlinear least squares curve fitting using the GraphPad 
Prism, version 6.01 (GraphPad Software, Inc.). The individual curves at different intervals (10.00am, 
12.00pm, 2.00pm, and 4.00pm) describing the relationship between output spike amplitude/slope (y) 
and stimulus intensity (x) at each stage of the cycle were fitted to a sigmoidal four-parameter 
Boltzmann function:  
Y=D+(A-D)/(1+exp((V50-X)/B)) 
A and D are the expected maximum and minimum responses, respectively. B is the Hill slope 
coefficient, and V50 is the stimulus strength expected to generate a half-maximal amplitude/slope 
response of the EP. The amplitudes and slope recorded at the highest stimulation intensities were not 
significantly different across time-points (data not shown) within each group and the maximum A 
was thus set to 100%. Constrained curve fitting (between 0% and 100%) and extra sum-of-squares F 
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test were then utilized to test the significance of differences between the V50 from the three groups 
of animals.  
Furthermore, the four V50 values calculated at each hour (10.00am, 12.00pm, 02.00pm, 04.00pm) 
were compared by a repeated-measure one-way ANOVA followed by a Dunnett’s multiple 
comparisons test.  
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Results 
Urethane caused a robust cortical slow wave activity  
In all animals (n = 16), we recorded the ECoG activity from both hemispheres. As previously 
described 1,2,28,32 the urethane anesthesia caused robust and persistent SWA of 0.1-4.0 Hz with large 
amplitude. Furthermore, the ECoG spectral analysis demonstrated that the dominant frequency 
remained within the SWA range (< 3 Hz, Fig. 2A) throughout the time course of the anesthesia in all 
animal groups, attesting the stability of the anesthesia.  
 
Urethane decreased the total power in slow wave activity range only in normal animals 
Although the SWA range (0.1-4 Hz) was the dominant frequency, its total power changed 
significantly during the 8 hours of urethane anesthesia. In fact, the total power of the SWA decreased 
significantly during the four different hours (10.00am, 12.00pm, 02.00pm, 04.00pm) and between the 
three groups of rats (ANOVA, F3, 39 = 5.26; P = 0.0038; F2, 13 = 4.74; P = 0.0283, respectively). 
However, only normal animals showed a significant decrease of the total power between 10.00 am 
and the following hours (n = 6; P < 0.05; 10.00am vs. 12.00pm: mean difference 0.062; 95% CI of 
difference 0.027 to 0.097, 10.00am vs. 02.00pm: mean difference 0.068, 95% CI of difference 0.033 
to 0.103; 10.00am vs. 04.00pm: mean difference 0.068, 95% CI of difference 0.033 to 0.103; Fig. 
2B). In Parkinsonian untreated (n = 5) and treated with APO (n = 5) animals, there were no clear 
changes (P > 0.05) of the SWA total power (Fig.2B). Of note, the total delta power at 10.00am in 
normal rats ( n = 6) was significantly higher than in non-treated (6-OHDA, n = 5) and treated (6-
OHDA+APO, n =5) Parkinsonian animals (P < 0.001, Control vs. 6-OHDA: mean difference 0.079; 
95% CI of difference 0.040 to 0.118, Control vs. 6-OHDA+APO: mean difference 0.053, 95% CI of 
difference 0.014 to 0.092; Fig. 2C). 
The total power of theta (5-7 Hz), beta (8-13 Hz) and gamma (15-35 Hz) remained unchanged during 
the time course in all groups (data not shown). 
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Urethane changed the corticocortical- and corticostriatal-evoked potentials excitability in normal 
rats 
In all animals (n = 16), the CC-EP and CS-EP amplitudes increased as a function of stimulus intensity, 
best fitted with a sigmoidal relationship. The four I-O curves of both the CC-EP and the CS-EP 
amplitude performed every 2 hours (10.00am, 12.00pm, 2.00pm, and 4.00pm) progressively shifted 
with time of recording (Fig. 3A,B upper plots). Non-linear regression analysis of the CC-EP and CS-
EP amplitude demonstrated that best fitted curves were significantly different (CC-EP: F6,32= 23.10, 
P <0.001; CS-EP: F6,32= 8.702, P <0.001; Fig. 3A,B upper plots). The V50, that is the stimulus 
strength able to give a half-maximal amplitude response of the EP, was lower for the I-O curves at 
10.00am (Fig. 3A,B lower plots) suggesting a stronger synaptic coupling (i.e. synaptic efficiency) 
because low current strength is required to drive both the CC- and the CS-EP (Table1 and Table2). 
The fit of the subsequent I-O curves (12.00pm, 2.00pm, and 4.00pm) showed a V50 increase attesting 
to a reduction of the excitability of the evoked responses (Table1 and Table2; Fig. 3A,B lower plots).  
The four V50 values of the CC- and the CS-EP obtained at 10.00am, 12.00pm, 2.00pm, and 4.00pm 
were significantly different (CC-EP: F1.2,6.2= 6.058, P <0.05; CS-EP: F1.7,8.7= 4.914, P <0.05; Fig. 
3A,B). Multiple comparison analysis showed a statistical difference in both the CC- and the CS-EP 
at 4.00pm versus 10.00am (Fig. 3A,B lower plots). 
 
Effect of urethane on the corticocortical- and corticostriatal-evoked potentials excitability in 
Parkisonian rats 
In 6-OHDA animals (n = 5), non-linear regression analysis of the CS-EP amplitude demonstrated that 
best-fitted I-O curves were not significantly different, leading to a shared curve for all four hours 
(F6,192= 0.410, P >0.05; Fig. 4 upper plot). The V50 values were not significantly different from each 
other (F1.1,4.4= 0.793, P = 0.43; Fig. 4 lower plot).  
In the Parkinsonian animals treated with APO (n = 5), non-linear regression analysis of the CS-EP 
amplitude demonstrated that the best-fitted I-O curves were significantly different (F6,192= 2.411, P 
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<0.05; Fig. 5 upper plot). In contrast to what was observed in control animals, the I-O curve at 2.00pm 
was the most leftward followed by the I-O curves at 12.00pm, 4.00pm, and 10.00am (Fig. 5 upper 
plot, Table 3). The four V50 values of the CS-EP obtained at the 10.00am, 12.00pm, 2.00pm, and 
4.00pm were not significantly different (F2.2,9.0= 0.998, P = 0.41; Fig. 5 lower plot).  
In both Parkinsonian treated and non-treated rats the CC-EP were unaffected by the time spent in 
urethane anesthesia (data not shown).  
 
Changes of the total power in the slow wave activity range correlate with the changes of 
corticostriatal-evoked potentials excitability only in naïve animals 
If urethane-induced SWA drives changes of corticostriatal excitability, the evoked response would 
be expected to vary with the magnitude of the cortical SWA. Hence, the relationship between SWA 
total power and CS-EP V50 was investigated. A significant positive correlation was found between 
the percentage of variation (4.00pm vs 10.00am) of both SWA total power and the V50 of the CS-EP 
only in control animals (r = 0.91, R2 = 0.835, p < 0.01, n = 6; Pearson's correlation, Fig. 6A). On the 
other hand, no correlation was observed in either 6-OHDA or 6-OHDA + APO animals (Fig. 6B,C) 
.  
 
Discussion  
Recent evidence suggest that the dopaminergic system is a strong modulator of cortical activity with 
regard to sleep-wake states. A recent study in humans with lower activity of DA reuptake transporter 
shows altered SWA after sleep deprivation.34 Indeed, the SWA is involved in pathophysiological 
aspects of PD.  
The present findings are obtained from urethane-induced long-lasting cortical SWA1,2 that is able to 
drive a cortical pattern comparable to natural sleep. 4,6,7  
Herein, the main message is twofold: (i) SWA promotes changes in synaptic efficiency in both cortex 
and striatum, exclusively in a DA preserved circuitry; (ii) Parkinsonian animals present lower SWA 
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total power at the beginning of the urethane-induced SWA. Particularly, we observed a progressive 
decrease of the SWA total power along with the cortico-cortical and cortico-striatal excitability 
measured trough EP responses. 
Similarly, in normal subjects the total power of SWA during NREM sleep is highest at sleep onset 
and decreases proportionally during time spent asleep.36 Although we did not examine the underlying 
mechanisms by which synaptic strength declines, we found that it depended on the time spent in 
urethane-induced SWA and on the integrity of the DAergic system.  
The evoked local field responses are a reliable readout of synaptic transmission suitable for our in 
vivo study.27 The SWA as well as the amplitude of the evoked responses, reflecting a sub-threshold 
phenomenon, are both directly related to the number of the neurons firing in unison according to the 
number, the strength, and the distribution of the synaptic bouton.25,27,37 In humans, the SWA increases 
in parallel with the cortical synaptic strength promoted by learning.38,39 Similarly, in experimental 
animals the infusion of BDNF increased the cortical synaptic strength and the SWA amplitude.40 
Furthermore, the CC-EPs in rats are higher after wakefulness and lower after sleep period 23 attesting 
to synaptic upscaling during awake state and downscaling during sleep. Our experimental data sustain 
the SHY postulating that the SWA is an index of cortical synaptic strength as well as a measure of 
sleep mediated synaptic scaling. 
The further role of the SWA as a contributor for synaptic downscaling remains without direct 
evidence but postulated19 by the SHY. The SHY holds that  the underlying slow oscillations of the 
SWA would promote changes of synaptic efficiency due to the sustained cortical firing during the 
depolarized up state1 able to depress synaptic strength as inferred in a computational model analysis.26 
Here we show that SWA changes are directly correlated with changes in corticostriatal synaptic 
strength in healthy animals.  
We observed that the total dominant frequency of the ECoG was constantly below 3 Hz during the 
eight hours of urethane anesthesia, although the total power of the same SWA showed a significant 
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reduction during the four periods of analysis without changes in other frequency bands. These 
observations could be explained by a sustained urethane-induced cortical SWA that promotes a 
reduction of its power over time. The negligible effect on the power of other frequency ranges (theta, 
beta and gamma) supports the view that this effect is specific to SWA. We observed that only the 
delta, i.e. the SWA power, selectively reduced during the eight hours of robust SWA. This supports 
a specific SWA mediated effect instead of an unspecific effect of urethane on cortical function. These 
data are reinforced by the findings on Parkinsonian rats that do not show a clear decay of the delta 
total power or changes of synaptic efficiency.  
An addition, a major result of our study was the higher SWA total power observed in healthy rats at 
the end of the wake time in comparison to Parkinsonian rats even after dopaminergic treatment. These 
findings suggest an impairment of synaptic strength build-up during the awake period in DA depleted 
animals. Indeed, Parkinsonian animals manifest an impairment of plasticity that is restored after 
levodopa treatment at least at striatal level.12 Of note, TMS studies have shown a similar impaired 
cortical plasticity also in drug naïve PD patients.41  
The lateralized 6-OHDA model could provide for misleading interpretation of the inter-hemisphere 
study. However, an increased nigro-striatal inter-hemisphere projection has been described after 
unilateral DA depletion.42 With this limitation in mind, in hemi-parkinsonian animals both the SWA 
power (recorded in the normal hemisphere) as well as the CC-EP remained unchanged during the 
time spent in urethane anesthesia. At cortical level, APO treatment did not restore this effect. For CS-
EP curves, however, DA depletion removed the reduction of excitability and this was restored by the 
DAagonist (APO). This is in accordance with the lack of cortico-striatal plasticity in vitro that 
recovers after DAergic treatment.43 However, the four I-O curves were different in comparison to 
normal animals (i.e. the rightward shifted curve was the 10.00am curve). We hypothesized that due 
to the pharmacokinetic short-lasting properties of APO,44 the recovery of the CS-EP is only 
incomplete. The post-synaptic action of APO could be another key factor for such a partial response.  
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Furthermore, the relationship between SWA and CS-EP strength was different across all groups. 
Indeed, naïve rats showed a strong positive correlation between changes of SWA power and of CS-
EP V50 suggesting that urethane-induced SWA contributes to controlling both cortical and striatal 
excitability. In contrast, this type of correlation was completely lost in DA denervated animals and 
was not recovered by APO treatment. This suggests that only a physiological tonic DA substitution 
would completely restore the physiological modulation of CS-EP by SWA.  
In agreement with our findings, the physiological corticostriatal plasticity strongly depends on DA 
system integrity and striatal DAergic denervation produces resilient biochemical and morphological 
changes.12,45,46 The DA dependency of the urethane-induced SWA effect was attested to by the partial 
reversibility of the progressive reduction of synaptic efficacy obtained by APO treatment. The effect 
observed by DA-agonist treatment exhibits some parallels with the clinical observation of motor 
performance amelioration after sleep in PD patients featured by longer duration of disease and motor 
fluctuations.16 Notably, PD patients with sleep benefit are more frequently under DA-agonist 
treatment. 16 
We emphasize that DA plays a crucial role for both physiological SWA activity and the homeostatic 
plasticity adjustment of the corticostriatal synapsis during sleep. This reinforces the need for an 
adequate DA replacement therapy during day and nighttime. In PD patients, the discontinuation of 
DA replacement therapy during the night could be responsible for aberrant synaptic changes that over 
the course of the disease could lead to pathophysiological changes such as observed in dyskinesia. 
12,46 
We are aware of some limitations of the present study: 1) It lacks a comparable anesthetic not able to 
induce cortical SWA. However, as above mentioned, the isolated effect on delta power suggests an 
unrelated effect of the anesthetic but rather a specific SWA mediated effect. 2) We do not compare 
another dopaminergic drug, such as levodopa, in order to investigate putative pre-synaptic DA-
mediated mechanism. 3) We do not assess the effect of dopaminergic treatment during the awake 
period in order to test a putative DA-mediated recovery of build-up synaptic strength.  
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Despite the above limitations, we can conclude that our results are in line with the hypothesized role 
of SWA on shaping synaptic strength over longer time scales. This is physiologically achieved during 
NREM sleep. Furthermore, our results also bear testimony to a fundamental role for physiological 
DA tone on homeostatic process, regulating SWA during the day and night which requires an 
adequate DAergic therapy. 
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Figures legends  
Figure 1. Study protocol and histological assessment. A. Flow chart of the study. Three groups of 
animals (control, Parkinsonian and Parkinsonian-treated animals) were anesthetized with urethane 
and submitted every 2 hours to an input-output (I-O) stimulation with increased stimulation currents. 
B. Schematic representation of the stimulation protocol. A stimulation electrode was placed in the 
frontal right cortex. A deep striatal electrode was placed within the striatum for the cortico-striatal 
evoked potential, while a screw electrode was placed on the frontal left cortex for the recording of 
both ECoG and cortico-cortico evoked potential. C. Histological coronal section depicting the 
goodness of the TH lesion on the right side lesioned hemisphere. D. Representation of a recorded CS-
EP. Field potential amplitude was measured between the N2 and P2 peak. 
 
Figure 2. ECoG spectral analysis. A. The mean dominant frequency of the ECoG during all the 8 
hours of recording. For all the animals (n = 16), we calculated the ECoG dominant frequency 
expressed during the time course of the urethane anaesthesia. The lines represent the mean dominant 
frequency in the control (turquoise, n = 6) and in Parkinsonian (red, n = 10). As shown both control 
and Parkinsonian expressed constantly a dominant frequency below 3 Hz within the delta SWA range. 
B. The total power of the delta frequency range (0.1-4 Hz) calculated for 10 minutes before each four 
I-O curves (10.00am; 12.00pm; 02.00pm; 04.00pm). We found a significant decreases a progressive 
reduction of the delta total power between 10.00am and the following hours (12.00pm; 02.00pm; 
04.00pm) only in the control animals. We did not observed significant changes in both 6-OHDA and 
6-OHDA APO treated rats although the latter show a tendency to have higher values at 10.00 am and 
12.00 pm.  
C. The total power of the delta frequency range (0.1-4 Hz) calculated for 10 minutes before each four 
I-O curves (10.00am; 12.00pm; 02.00pm; 04.00pm). We observed a significant difference only at the 
end of the awake period (10.00am) in normal animals.  
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Data are expressed as mean±SEM; * = P < 0.05; n.s. = not significant; § = P < 0.001 Control vs 6-
OHDA and Control vs 6-OHDA+APO 
 
Figure 3. Normalized evoked response amplitude in control animals (n = 6). A. The I-O curve of CC-
EP amplitude performed in the four tested hours (10.00am; 12.00pm; 02.00pm; 04.00pm). The 
stimulus strength necessary to give the 50% response (V50) was lower in the I-O curve performed at 
10.00 am (pink line) in comparison with the other I-O curves. While the V50 higher value was 
obtained with the last I-O curve (blue line). B. Similarly, the I-O curves of the CS-EP showing a 
significant different curve fitting for the four hours in which the first (10.00am, pink line) has the 
lower V50 value while the last (4.00pm, blue line) has the highest one. 
V50 = the stimulus strength necessary to give the 50% response; data are expressed as mean  
 
Figure 4. Normalized evoked response in 6-OHDA animals (n = 5) and Parkinsonian treated with 
APO (n =5). A. The curve fitting of the I-O curve of the CS-EP amplitude was not significant different 
between the four hours. A shared curve fit is showed on the plot. B. The Parkinsonian animals treated 
with APO showed a significant different curve fit of the I-O curve amplitude. However, the first I-O 
curve performed on the morning (10.00am) showed the highest V50 level, i.e. the lasses excitability. 
The lower V50 was observed at 02.00pm when three APO challenge have been performed.  
V50 = the stimulus strength necessary to give the 50% response; data are expressed as mean  
 
Figure 5. Evoked response in the three groups of animals at the four examined hours. The maximal 
V50 difference between groups was observed at 10.00am with a progressive reduction between 
control and 6-OHDA animals up to become not significant at 4.00pm in which a shared black curve 
fit is shown.  
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Figure 6. Correlation analysis between changes of SWA total power and V50 measured at 10.00am 
and 4.00pm. Only in control, we observed a statistical significance of Pearson correlation with an 
R2 = 0.835. Whilst no correlation has been observed in the other two groups of animals.  
 
 
